1. Home
  2. SGHC vs GKOS Comparison

SGHC vs GKOS Comparison

Compare SGHC & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SGHC

Super Group (SGHC) Limited

HOLD

Current Price

$10.69

Market Cap

5.4B

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$102.14

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGHC
GKOS
Founded
2020
1998
Country
Guernsey
United States
Employees
N/A
1094
Industry
Services-Misc. Amusement & Recreation
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
6.0B
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
SGHC
GKOS
Price
$10.69
$102.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
14
Target Price
$17.33
$133.07
AVG Volume (30 Days)
2.4M
634.7K
Earning Date
05-07-2026
04-29-2026
Dividend Yield
3.88%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$507,442,000.00
Revenue This Year
$29.10
$23.39
Revenue Next Year
$14.20
$27.46
P/E Ratio
$20.80
N/A
Revenue Growth
N/A
32.33
52 Week Low
$5.59
$73.16
52 Week High
$14.38
$130.23

Technical Indicators

Market Signals
Indicator
SGHC
GKOS
Relative Strength Index (RSI) 52.96 39.00
Support Level $10.59 $81.54
Resistance Level $11.60 $106.52
Average True Range (ATR) 0.49 3.96
MACD -0.05 -0.91
Stochastic Oscillator 36.18 23.74

Price Performance

Historical Comparison
SGHC
GKOS

About SGHC Super Group (SGHC) Limited

Super Group (SGHC) Ltd is a holding company that operates online sports betting and gaming businesses. The company's reportable segments are Betway, Spin, and Other. A majority of its revenue is generated from the Betway segment, which is a single-brand online sports betting and casino offering with licenses to operate throughout Europe, the Americas, and Africa. Spin is the company's multi-brand online casino offering, having a diverse portfolio of casino brands such as Jackpot City, Spin Casino, Dream Bingo, Mirror Bingo, etc., designed to be culturally relevant globally while aiming to offer a wide range of casino products. Geographically, the company generates maximum revenue from Africa and Middle East, followed by North America, Europe, Asia-Pacific, and South/Latin America.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: